BeOne Medicines
ONC
#717
Rank
โ‚น3.065 T
Marketcap
โ‚น26,692
Share price
2.20%
Change (1 day)
18.61%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚น360.95 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are โ‚น360.95 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น343.58 B54.71%
2024-12-31โ‚น222.07 B17.62%
2023-12-31โ‚น188.80 B14.31%
2022-12-31โ‚น165.16 B-7.66%
2021-12-31โ‚น178.85 B41.24%
2020-12-31โ‚น126.63 B180.12%
2019-12-31โ‚น45.20 B30.34%
2018-12-31โ‚น34.68 B49.95%
2017-12-31โ‚น23.12 B543.35%
2016-12-31โ‚น3.59 B27.46%
2015-12-31โ‚น2.82 B59.79%
2014-12-31โ‚น1.76 B-43.45%
2013-12-31โ‚น3.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
OPKO Health
OPK
โ‚น62.62 B-82.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น1.14 B-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA